
Janus Henderson Global Life Sciences Fund
JNGLX
Updated: 04/11/2026, 13:12:08
No historical data available
This fund aims to achieve its investment objective by typically allocating a minimum of 80% of its net assets (plus any capital borrowed for investment purposes) to companies that the portfolio manager believes exhibit a life science orientation. As a fundamental principle guiding its pursuit of life science-focused companies, the fund also has a policy to normally invest at least 25% of its total holdings in businesses formally classified within the "life sciences" sector.
No summaries found.
- Share price
- $92.77
- Market cap
- $5.80B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- N/A
- Employees
- N/A
- IPO date
- 04/01/1999
- Beta
- 0.66
- Last dividend
- $0.00
- Day range
- $92.65 – $92.77
- 52-week range
- $75.42 – $94.22
- 1-day performance
- 0.13%
- 1-year performance
- 23.00%
- Current drawdown (1Y)
- -1.54%
- CIK
- 0000277751
- CUSIP
- 47103E700
- ISIN
- US47103E7004
- Created
- 07/12/2025, 04:53:05
- Last update
- 04/11/2026, 13:12:08
Track Janus Henderson Global Life Sciences Fund with an AI analyst
See which prediction-market events move JNGLX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.